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Malignant astrocytomas are highly invasive neoplasms
infiltrating diffusely into regions of normal brain. Migra-
tion or invasion of tumor cells into normal tissue is a
principal cause of mortality and is thought to be a
multi-factorial process, consisting of cell interaction
with ECM and adjacent cells, as well as accompanying
biochemical processes supportive of active cell move-
ment. Rho family members are known to regulate malig-
nant transformation motility and invasion of cancer
cells, but the clinicopathological significance of Rnd3
remains unclear. We evaluated the protein expression
level of RhoE in gliomas tissues, cell lines and brain
tumor initiating stem cells (BTSCs). Results showed that
the expression of RhoE was significantly higher in
patients with highly invasive gliomas. Next, we con-
structed a mammalian expression plasmid containing
human RhoE and ectopically expressed it in U87. Ecto-
pic expression of RhoE was found to induce membrane
ruffle formation, increased migration and invasion both
in vitro and in vivo and altered the relative levels of
GTP-bound Rac1 and RhoA. Finally RhoE siRNA in the
glioma cell line U251 inhibited cell invasion in vitro. In
conclusion, the expression of RhoE appears to have a
role in the pathogenesis of gliobstoma multiforme.
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